Auro Laboratories Limited has submitted the clippings of newspaper publications of the Un-Audited Financial Results for the quarter ended June 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Auro Laboratories Limited has submitted to BSE the newspaper clippings of its Q1 FY26 (quarter ended June 30, 2025) unaudited financial results, as required under SEBI Listing Regulations. Total income from operations fell sharply to Rs. 319.07 lakhs, compared to Rs. 592.32 lakhs in Q1 FY25 and Rs. 752.94 lakhs in the preceding quarter (Q4 FY25). The company slipped into a loss, reporting a net loss after tax of Rs. 10.55 lakhs versus a profit of Rs. 75.27 lakhs a year ago. Basic and diluted EPS turned negative at Rs. (0.17) from Rs. 1.21 in Q1 FY25. Equity share capital remained unchanged at Rs. 623.25 lakhs. The results were published in Mumbai Lakshdeep (Marathi) and Active Times (English) on August 17, 2025, after Board approval on August 14, 2025.
A steep drop in revenue and a swing to quarterly loss signal weakening operations, which is likely to weigh on investor sentiment and could pressure the stock price in the near term.